Ultan McDermott
@ultanmcd.bsky.social
Oncologist. Chief Scientist at AstraZeneca. Trained at @MGHCancerCenter. Interested in the evolution of drug resistance. Views are my own.
Antibody drug conjugates are showing promise across a range of solid tumours and haem malignancies - if you're confused by DAR, linkers, payloads....this is a great starting place! www.nature.com/articles/d41...
September 8, 2024 at 7:44 AM
Antibody drug conjugates are showing promise across a range of solid tumours and haem malignancies - if you're confused by DAR, linkers, payloads....this is a great starting place! www.nature.com/articles/d41...